Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Acthar on Proteinuria and Disease Progression in IgA Nephropathy Patients With Nephrotic Range Proteinuria

NCT02382523 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT02382523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02382523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Acthar on Proteinuria and Disease Progression in IgA Nephropathy Patients With Nephrotic Range Proteinuria
Lead sponsor
Baylor College of Medicine
Phase
Phase 4
Overall status
Withdrawn
Start date
February 28, 2015
Completion date
January 31, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iga nephropathy, proteinuria